CD274 and hepatocellular carcinoma: patients with high-risk scores were accompanied by high TMB and higher levels of PDL-1 expression, suggesting an immune microenvironment of HCC could be affected by four-gene, and having shown that immunotherapy would be more effective in the high-risk score subgroup.